The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women.
Abstract
The present study tests the mechanistic postulate that estrogen confers resistance to negative feedback by systemic IGF-I. To this end, eight postmenopausal women received a constant iv infusion of recombinant human (rh)IGF-I (10 micro g/kg.h x 6 h) and saline in randomized order on the 10th day of supplementation with oral estradiol (E(2)) and placebo (Pl). GH secretion was quantitated by 10-min blood sampling, immunochemiluminometry assay, and deconvolution analysis. Administration of E(2) compared with Pl followed by saline infusion: 1) stimulated pulsatile GH secretion ( micro g/liter.6 h), viz., 12 +/- 3.3 (Pl) and 18 +/- 4.6 (E(2)) (mean +/- SEM, paired comparison, P < 0.05); 2) halved the time latency (min) to achieve peak GH secretion after GHRH injection, 24 +/- 2.2 (Pl) and 12 +/- 2.1 (E(2)) (P < 0.01); and 3) did not alter the mass of GH secreted ( micro g/liter) in response to a maximally effective dose of GHRH, 30 +/- 7.2 (Pl) and 37 +/- 11 (E(2)). Exposure to E(2) compared with Pl followed by rhIGF-I infusion: 1) accelerated the rate of decline of GH concentrations by 3.3-fold, viz., absolute slope ( micro g/liter.1000 min), 3.8 (range, 2.5-5.0) (Pl) and 12 (range, 10-14) (E(2)) (P < 0.001); 2) augmented the algebraic decrement in GH concentrations ( micro g/liter) enforced by rhIGF-I infusion, 0.73 +/- 0.21 (Pl) and 1.6 +/- 0.25 (E(2)) (P < 0.01); 3) halved the time delay (min) to peak GHRH-induced GH secretion, 20 +/- 1.2 (Pl) vs. 10 +/- 1.3 (E(2)) min (P < 0.01). In contradistinction, E(2) did not alter: 1) the capability of rhIGF-I to suppress GHRH-stimulated GH secretory burst mass significantly, viz., by 50 +/- 8% (Pl) and 52 +/- 14% (E(2)) (P < 0.05 each vs. saline); 2) the hourly rate of rise of infused (total) IGF-I concentrations; and 3) total and ultrafiltratably free IGF-I concentrations ( micro g/liter) attained at the end of the two rhIGF-I infusions. In summary, compared with Pl, E(2) supplementation in postmenopausal women: 1) amplifies endogenously driven GH secretory-burst mass; 2) initiates rapid onset of GHRH-stimulated GH release; and 3) potentiates IGF-I-dependent suppression of unstimulated GH concentrations. Based upon companion modeling data, we postulate that E(2) facilitates the upstroke and IGF-I enforces the downstroke of high-amplitude GH secretory bursts in estrogen-replete individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Equivalent basal GH secretion in a low and high E 2 milieu indicates that E 2 is not a primary determinant of nonpulsatile GH secretion in the human (1,39).”
From Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp (2005) · cites this paper as [39]
In the citing paper
“clinical investigations indicate that E 2 supplementation in postmenopausal women augments stimulation by GHRP-2 and submaximal drive by GHRH”
From Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp (2005) · cites this paper as [39]
Citations
Cites
Giustina, A., & Veldhuis, J. D. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.6.0353 · Cited by 1,253 · cited 3×
“progestin) via oral, higher-dose transdermal, iv, intranasal, im, or intravaginal routes can reduce total IGF-I concentrations in hypogonadal girls and women, male-to-female transsexual patients, and men with prostatic carcinoma (1, 18).”
BackgroundSelf-citationNeuroendocrine Control of Growth Hormone Secretion
Müller, E. E., Locatelli, V., & Cocchi, D. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.2.511 · Cited by 634
Veldhuis, J. D. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3209 · Cited by 389
Self-citationReceptor-Mediated Peptide Transport through the Blood-Brain Barrier*
PARDRIDGE, W. M. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-3-314 · Cited by 313 · cited 1×
“Because systemic estrogens and intact insulinomimetic peptides have access to the hypothalamus and pituitary gland (1, 8, 33), available data do not allow unique localization of the site(s) of interaction of IGF-I and estrogen in mediating enhanced negative feedback, as observed here.”
BackgroundFree insulin‐like growth factors (IGF‐I and IGF‐II) in human serum
Frystyk, J., Skjærbæk, C., Dinesen, B., & Ørskov, H. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00602-4 · Cited by 306
Self-citationYAMASHITA, S., & MELMED, S. (1986) · Endocrinology · doi:10.1210/endo-118-1-176 · Cited by 265
Regulatory mechanisms of growth hormone secretion are sexually dimorphic.
Jaffe, C. A., Ocampo-Lim, B., Guo, W., Krueger, K., Sugahara, I., DeMott-Friberg, R., Bermann, M., & Barkan, A. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2908 · Cited by 236 · cited 1×
“In one comparison by gender, constant iv infusion of rhIGF-I for 24 h: 1) elevated IGF-I concentrations more in women than men (mean absolute difference, 300 g/liter); 2) decreased GH concentrations more in women than men in the daytime awake fed state but did the opposite during overnight sleep when fasting; and 3) i…”
BackgroundHartman, M. L., Clayton, P. E., Johnson, M. L., Celniker, A., Perlman, A. J., Alberti, K. G., & Thorner, M. O. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116480 · Cited by 192
Veldhuis, J. D., Roemmich, J. N., & Rogol, A. D. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6697 · Cited by 165
Self-citationFARIA, A. C. S., Veldhuis, J. D., Thorner, M. O., & Vance, M. L. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-3-535 · Cited by 147 · cited 1×
“Basal (nonpulsatile) GH secretion was estimated by waveform-independent deconvolution analysis assuming a priori biexponential kinetics (23, 24).”
MethodSelf-citation
Cited by
Endocrine Control of Body Composition in Infancy, Childhood, and Puberty
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., Rogol, A. D., Lovejoy, J. C., Sheffield-Moore, M., Mauras, N., & Bowers, C. Y. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0038 · Cited by 452
Self-citationSomatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., & Bowers, C. Y. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0006 · Cited by 236
Self-citationMakrantonaki, E., Vogel, K., Fimmel, S., Oeff, M. K., Seltmann, H., & Zouboulis, C. C. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.07.005 · Cited by 96
Skin and brain age together: The role of hormones in the ageing process
Makrantonaki, E., Schönknecht, P., Hossini, A. M., Kaiser, E., Katsouli, M.-M., Adjaye, J., Schröder, J., & Zouboulis, C. C. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.08.005 · Cited by 91
“Supplementation of middle-aged and older men with high-dose testosterone attenuated IGF-I feedback-dependent inhibition of GH secretion (Veldhuis et al., 2004), whereas the acute administration of estradiol accentuated IGF- I-induced inhibition of GH secretion (Veldhuis et al., 2004).”
InfluentialChen, J., Højlund, K., Beck‐Nielsen, H., Christiansen, J. S., Ørskov, H., & Frystyk, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0039 · Cited by 73
Self-citation
Metadata
- Authors
- Veldhuis, J. D., Anderson, S. M., Kok, P., Iranmanesh, A., Frystyk, J., Ørskov, H., & Keenan, D. M.
- Affiliations
- Mayo Clinic (US)
- Leiden University Medical Center (NL)
- Salem VA Medical Center (US)
- Aarhus University Hospital (DK)
- University of Virginia (US)
- Corresponding author
- Veldhuis, Johannes D.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-03
- Volume
- 89
- Issue
- 3
- Pages
- 1312-1318
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2004053614
- Semantic Scholar
- fed355828e7e41b6b3e93118398a4b551a460548
- Cited by
- 34
- References
- 36
- Citations by year
- 2022: 1 · 2018: 1 · 2015: 2 · 2014: 1 · 2012: 1
- FWCI
- 4.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- National Institute on Aging (K01 AG-19164, R01 NIA AG 14799, K01AG019164)
- National Center for Research Resources (RR-00585, M01RR000847, M01RR000585, M01-RR 00847)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- estradiol, growth hormone secretion, insulin-like growth factor I, negative feedback, IGF-I resistance, postmenopausal women, GHRH stimulation, deconvolution, pulsatility index
- MeSH terms
- Drug Interactions, Estradiol, Female, Humans, Insulin-Like Growth Factor I, Middle Aged, Models, Biological, Phosphorus, Potassium, Prospective Studies, Pulsatile Flow, Recombinant Proteins, Postmenopause, Human Growth Hormone, Feedback, Physiological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women. https://app.cochat.ai/papers/10.1210/jc.2003-031482
- The paper
- Veldhuis, J. D., Anderson, S. M., Kok, P., Iranmanesh, A., Frystyk, J., Ørskov, H., & Keenan, D. M. (2004). Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2003-031482
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.